Alvotech (ALVO) Form 6-K — Jun 17, 2026
Alvotech has priced a public offering and concurrent private placement, issuing a total of approximately 43.9 million ordinary shares at a price of $3.75 per share. The public offering consists of 22.7 million firm shares with a fully exercised underwriter option for an additional 3.4 million shares, expected to generate roughly $91.2 million in net proceeds. The capital raise occurs after the company received Complete Response Letters from the FDA for its Biologics License Applications for AVT03, AVT05, and AVT06, citing deficiencies at its Reykjavik manufacturing facility.
Key figures
- Offering Price
- 3.75
- Shares Offered
- 43,893,333
- Pipe shares
- 17,826,666
- Greenshoe shares
- 3,400,000
- Pipe gross proceeds
- $66.85 million
- Public offering shares
- 26,066,667
- Public offering net proceeds
- $91.20 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.